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hematopoiesis. 15, 16 Furthermore, vascular sinusoids constitute a dedicated interface for cell exchanges with the peripheral circulation. In a mouse model, we showed that type 1 diabetes mellitus causes microvascular rarefaction, resulting in critical hypoperfusion, depletion of SCs at the level of the endosteal niche, and altered transendothelial cell trafficking. 17 It would be of paramount importance to understand whether similar microvascular pathology occurs in BM of patients with diabetes mellitus. Current knowledge is limited to flow cytometry analysis of aspirates, which showed reduction of CD34 pos -PCs in BM of diabetic patients. 5 However, this sampling procedure is not suited to define the anatomic structure of the marrow and may provide inaccurate SC counts if the marrow is remodeled. Moreover, the molecular mechanisms underlying diabetes mellitus-induced SC depletion are incompletely understood. We showed that experimental diabetes mellitus causes an elevation in reactive oxygen species, infringes on DNA integrity, and induces apoptosis of Sca-1 pos c-Kit pos cells. 17 In addition, signaling mechanisms that maintain the self-renewal capacity and prevent senescence of SCs, like the polycomb group gene Bmi-1, 18 are downregulated in BM cells from diabetic mice. 13 Recent evidence indicates that microRNAs (miRs) regulate the maturation of different hematopoietic lineages. [19] [20] [21] In particular, a restricted subset of miRs expressed in CD34
pos HSCs is hierarchically organized in a circuitry that controls proliferation, viability, and differentiation. 21, 22 Among HSC-associated miRs, miR-221 reportedly regulates terminal sta ges of erythropoiesis via repression of c-Kit, whereas miR-155 acts upstream of miR-221 holding HSCs at an early stem-progenitor stage through inhibition of differentiation-associated molecules, like CCAAT/enhancer-binding protein-β, cAMP response elementbinding protein, JUN and FOS. 22, 23 In addition, miR-155 inhibits the forkhead transcription factor FOXO3a. 24 In hematopoietic cells with incurred DNA damage, FOXO3a induces cell cycle arrest and apoptosis, via transcriptional regulation of the cyclin-dependent kinase inhibitor p27 Kip1 and proapoptotic Bcl-2 family member Bim. [25] [26] [27] By inhibiting FOXO3a, miR-155 exerts prosurvival effects in HSCs.
The present study examines the damaging action of diabetes mellitus on human BM using femoral bone specimens collected from orthopedic surgery. To determine whether macrovascular disease can further disrupt BM integrity, we also studied patients with type 2 diabetes mellitus (T2DM) undergoing amputation for critical limb ischemia (CLI). Furthermore, we investigated the influence of diabetes mellitus and high glucose (HG) on miR expression in CD34 pos immunosorted BM PCs and the ability of miR-155 to reverse FOXO3a upregulation in HG-challenged CD34 pos cells.
Methods
A Supplemental Methods section is available in the Online Data Supplement.
Patients and Study Protocol
The study complied with the principles stated in the Declaration of Helsinki and was covered by institutional ethical approval (protocol number 20/2010). Eligible subjects were screened from a consecutive series referring to MultiMedica Hospital for hip replacement surgery (nondiabetic controls and T2DM patients) or limb amputation (T2DM patients with CLI) from August 2010 to November 2012. T2DM and CLI were defined according to the American Diabetes Association and the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), respectively. 28 Exclusion criteria were acute infection, immune diseases, current or past hematologic disorders or malignancy, drug-induced diabetes mellitus, unstable angina, recent (within 6 months) myocardial infarction or stroke, liver failure, dialysis because of renal failure, pregnancy, and lack of consent to participate in the study. Online Table I illustrates main clinical data of the 82 subjects who entered the study.
Immunohistochemistry, flow cytometry, and molecular biology analyses were performed on femoral head leftovers from orthopedic surgery and proximal part of amputated femurs. In addition, a 30 mL peripheral blood (PB) sample was obtained by venipuncture the day before interventional procedures.
Results
Characteristics of the Study Population
As shown in Online Table I , groups were similar with regard to age and sex distribution. T2DM patients showed a higher body mass index than controls and T2DM+CLI, whereas the T2DM+CLI group had the highest percentage of smokers and a longer duration of diabetes mellitus. Hypertension was more frequent in the 2 diabetic groups than in controls, and cardiovascular complications were common in T2DM+CLI patients. Insulin was the preferred antidiabetic medication in T2DM+CLI, whereas T2DM patients were mainly treated with oral antidiabetic drugs including glitazones. Between 40% and 52% of diabetic patients were taking statins. Fasting glucose was higher in the 2 diabetic groups, especially in T2DM+CLI.
Diabetes Mellitus Alters BM Composition
Histomorphometry demonstrates a remarkable remodeling of BM from diabetic patients, consisting of decreased hematopoietic tissue, fat deposition, and bone rarefaction ( Figure 1A and 1B). The effect of diabetes mellitus was significant, incremental in T2DM+CLI patients and independent of background factors (Online Table III ). Multiple regression analysis showed that the dependent variables, hematopoietic and fat fractions, can be predicted by grouping factor, fasting glucose and duration of diabetes mellitus, with no effect of other independent variables except for body mass index, which in association with duration of diabetes mellitus predicts the abundance of fat in BM (Online Table V 
Diabetes Mellitus and CLI Additively Reduce Vascular Density in Human BM
We next assessed the marrow microvasculature by immunohistochemistry. Capillaries were recognized as CD31-positive structures whose lumen-size does not exceed the diameter of an erythrocyte, whereas venous sinusoids were identified as larger irregular structures containing several erythrocytes ( Figure  1C ). Furthermore, microvessels and arterioles were identified by confocal and fluorescence microscopy using the endothelial marker von Willebrand factor and the vascular smooth muscle cell marker α-smooth muscle actin ( Figure 1D ).
Analysis of microvascular density identified a significant difference among groups for all sets of vascular structures (P=0.005; Figure 2E ). Pairwise comparison indicates a large decrease of capillary density in BM of T2DM patients (P<0.05 versus controls) and a further reduction of all 3 vascular fractions in T2DM+CLI patients (P<0.01). The effect of diabetes mellitus on BM microvascular density was confirmed when considering background covariates (Online Table III ). In multiple regression analysis, the dependent microvascular variables were predicted by grouping factor, duration of diabetes mellitus, and fasting glucose, in linear combination with hypertension as 
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far as capillaries and sinusoids are concerned (Online Table V) . Furthermore, we found that vascular density is directly correlated with the hematopoietic fraction and inversely correlated with fat abundance in BM (P<0.01 for both comparisons). Altogether, these data indicate that diabetes mellitus causes microangiopathy in human BM, with vascular rarefaction being aggravated by CLI. Among associated risk factors, hypertension interacts with diabetes mellitus in influencing capillary and sinusoid density.
Diabetes Mellitus Reduces the Abundance of Hematopoietic Progenitors in BM
BM-derived CD34 pos cells are a well-characterized population that have been used for hematopoietic reconstitution and Figure 2B and Online Figure I ).
We next used multicolor flow cytometry for quantification of various cell populations in BM and PB ( Figure 3A) .
pos cells were reduced in BM of T2DM (P=0.02 versus controls) and T2DM+CLI patients (P=0.004), but did not differ between the diabetic groups (Figure 3Bi ), with these data being confirmed by ANCOVA (Online Table III ). In contrast, PB CD45 dim CD34
pos cells were similar in control and diabetic patients (Figure 3Bii ). The relative abundance of CD45 dim CD34
pos cells in BM could be predicted independently by grouping factor, duration of diabetes mellitus, and fasting glucose in the multiple regression model (Online Table V ).
The surface antigen CD133, a prominin 5 transmembrane glycoprotein 1, has been used to identify primitive hematopoietic and nonhematopoietic PCs 31 endowed with proangiogenic and healing activities in animal models 32 and patients with acute myocardial infarction. [33] [34] [35] We found that CD45 Table  III ). The levels of CD45 dim CD133 pos CD34 pos cells were predicted by grouping, duration of diabetes mellitus, and fasting glucose (Online Table V Table V) .
We also verified the abundance of proangiogenic PCs defined as CD34 pos mononuclear cells. 42, 43 This cellular subpopulation was reduced in BM and PB of both diabetic groups, with no difference between T2DM and T2DM+CLI (Figure 4Bi-4Biii) . However, this effect was attenuated when considering other covariates (Online Table  III ). Nonetheless, the reduction of the PB cell fraction was predicted by grouping factor (Online Table V) . Furthermore, a recent study showed that BM CD31 pos cells are enriched of highly angiogenic cells. 44 However, we found no difference among groups regarding this cell population (data not shown).
We next verified the influence of diabetes mellitus on lineage committed hematopoietic cells ( Altogether, these data indicate that diabetes mellitus causes a selective reduction of endothelial PCs in BM and PB, without altering the abundance of lineage committed hematopoietic cells with exception of NK lymphocytes which were augmented in BM. Figure II) . However, in multiple regression analysis, diabetes mellitus was not a predictor of cKit pos PCs.
Effect of Diabetes Mellitus on Non-HSCs
Activation of the Proapoptotic FOXO3a Signaling Pathway in BM CD34 pos Cells
We investigated the expression levels of miR-155 and its validated target FOXO3a 24 in CD34 pos immunosorted BM PCs. Results indicate a downregulation of miR-155 in CD34 pos -PCs from diabetic patients compared with controls (P=0.019) ( Figure 6A ). In contrast, miR-221 did not differ among groups (data not shown). Moreover, we found FOXO3a mRNA levels to be increased in BM CD34 pos -PCs of diabetic patients (P=0.004) ( Figure 6B ) and inversely correlated to miR-155 levels (R 2 =−0.41; P=0.002) ( Figure 6C ). Of note, in situ analysis of FOXO3a expression showed a remarkable increase of the transcription factor in BM cells from both diabetic groups (P<0.0007) (Figure 6Di and 6Dii), with evidence of nuclear translocation which is required for transcriptional activation of target genes (Figure 6Diii and 6Div) . In line, we found that the FOXO3a targets p21 and p27 kip1 are upregulated in CD34 pos cells from diabetic patients (P=0.001 and 0.006, respectively) ( Figure 6E and 6F). The effect of diabetes mellitus on miR-115, FOXO3a, and p21 was confirmed when considering background covariates (Online Table VI ). P21 and p27 kip1 inhibit cell cycle progression by binding to, and inactivating, cyclindependent kinase complexes. Analysis of cell cycle by flow cytometry confirmed that CD34 pos cells from diabetic BM are stalled at the G1 checkpoint and undergo apoptosis with high frequency (Online Figure III) .
We next investigated whether in vitro exposure to HG mimics diabetes mellitus in altering the miR-155/FOXO3a/ p21/p27 kip1 signaling pathway in CD34 pos -PCs. We found that HG decreases cell counts and miR-155 levels and increases FOXO3a (Online Figure IVA-IVC) . Moreover, HG increases the levels of p21 and p27 kip1 (Online Figure IVD and IVE). The osmotic control mannitol did not alter the expression of miR-155 and related target genes (Online Figure V) .
To verify whether miR-155 overexpression can rescue the effect of HG on target genes, we transfected HG-challenged CD34 pos cells with pre-miR-155 and confirmed that transfection results in upregulation of related mature miR (Online Figure VI) . Of note, forced expression of miR-155 contrasted the diminishing effect of HG on CD34 pos cell counts and abrogates the HG-induced upregulation of FOXO3a, p21,
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and p27 kip1 ( Figure 7A and 7B). Finally, in inductive colony forming unit assays on HG-challenged CD34 pos cells, miR-155-transduced cells generated fewer myeloid and erythroid colonies. Furthermore, the colonies generated by miR-155-transduced cells were smaller than controls ( Figure 7C ).
Discussion
To the best of our knowledge, this is the first study showing the damaging effect of diabetes mellitus on BM SCs and their microvascular environment in human subjects. We demonstrate for the first time the presence of microangiopathy in BM of diabetic patients. Furthermore, we screened a large spectrum of SCs/PCs and mature hematopoietic cells in BM and PB by flow cytometry. Results newly document that the BM of diabetic patients is depleted of hematopoietic and proangiogenic PCs but not of differentiated hematopoietic cells. Finally, we show that both diabetes mellitus and HG alter the miR-155/ FOXO3a/p21/p27 kip1 signaling pathway, which represents a crucial mechanism controlling human CD34 pos -PC renewal and differentiation. Importantly, forced expression of miR-155 inhibits the inductive effect of HG on the FOXO3a/p21/ p27 kip1 trio and reduces differentiation of CD34 pos -PCs in a colony forming unit assay.
Diabetic Microangiopathy in Human BM
A prominent feature of diabetic BM consists of substitution of the hematopoietic component with adipose tissue. Interestingly, the effect of diabetes mellitus on marrow composition was independent of background factors, with exception of fat accumulation which was also predicted by the combination of duration of diabetes mellitus and body mass index. Although additional investigation is needed to interpret the relationship between fatty infiltration of the marrow and obesity, evidence indicates that BM adipocytes could contribute to inhibit hematopoiesis in an obese model of T2DM. 48 We found a direct correlation between vascular rarefaction and marrow remodeling, in line with the concept that a reduction of nurturing vasculature is detrimental for SC homeostasis. Of note, regression analysis indicates that, besides grouping factor, both duration of diabetes mellitus and hypertension are good predictors of capillary and sinusoid rarefaction, whereas arteriole density could be predicted only by variables inherent to diabetes mellitus, that is, disease duration and fasting glucose. The relationship between glycemic control and hypertension in the development of microangiopathy in peripheral organs is well documented. In CLI patients, who showed the most striking microvascular remodeling, analyses were performed on the proximal part of the amputated femoral bone which contains healthy tissue. We cannot exclude that the different anatomic source, in addition to ischemia, might have an impact on the incremental reduction of vascularity observed in this category. pos PCs in BM of diabetic patients. In contrast, lineage committed hematopoietic cells, including B and T lymphocytes, were similarly abundant or even increased, as in the case of NK subpopulation. Altogether, these findings newly indicate a disparity in the depleting effect of diabetes mellitus on different hematopoietic cell lineages, which might contribute to the altered spectrum of circulating cells. Importantly, the dominant influence of diabetes mellitus on these cellular endpoints was confirmed by analysis of associated risk factors and confounding variables.
Diabetes Mellitus Impinges on Master Molecular Regulators of Hematopoiesis
The present study highlights new molecular mechanisms that may account for HSC depletion in diabetes mellitus. Results of cell cycle analysis show that freshly sorted CD34 pos -PCs from BM of diabetic patients are held in G 1 phase, the typical restriction checkpoint where HSCs are cycle-arrested to prevent accrual of DNA damage. Moreover, diabetic BM cells show increased apoptosis, as assessed by immunohistochemistry and cell cycle analysis.
FOXO transcription factors are typically involved in enforcing cell cycle checkpoints in hematopoietic cells with DNA damage. 27 A potential mediator of FOXO-induced cell cycle arrest as well as of irreversible progression toward cell apoptosis is p27 kip1 , a cyclin-dependent kinase inhibitor that reportedly reduces proliferation and survival of HSCs. 49 We found that FOXO3a and downstream mediators, p21 and p27 kip1 , are remarkably upregulated in CD34 pos -PCs from BM of diabetic patients, with these transcriptional changes being associated with reduction of cell viability. In vitro experiments challenging CD34 pos cells with HG confirm that glucose is sufficient to activate the proapoptotic signaling pathway in healthy HSCs.
MiRs regulate major cellular processes, including metabolism, apoptosis, and differentiation and also participate in the pathogenesis of human diseases. [50] [51] [52] Seminal studies using conditional deletion of Dicer, which disrupts miR processing, revealed critical roles of miRs during development of hematopoietic cell lineages. 53, 54 In particular, miR-155 regulates early stages of hematopoiesis through inhibition of multiple genes implicated in HSC survival and differentiation, such as the human FOXO3a gene. 22 Current knowledge, however, is mainly centered on the implication of miR-155 in inflammation and cancer. 55 Intriguingly, a recent study showed that circulating levels of miR-155 are lower in patients with coronary artery disease compared with healthy controls, with an additive diminishing effect of diabetes mellitus. 56 It remains unknown what is the source of circulating miR-155 and whether a reduction of miR-155 expression in BM-derived cells can contribute to this defect.
Here, we report for the first time that miR-155 expression is reduced in BM CD34 pos cells from diabetic patients and inversely correlated with levels of its validated target FOXO3a. Importantly, the inhibitory effect on miR-155 and the increase of FOXO3a, p21 and p27 kip1 by diabetes mellitus were independent of other background factors and all replicated by challenging healthy CD34 pos cells with HG. To establish causality, we next asked whether miR-155 would prevent the effects of HG. Results indicate that forced expression of miR-155 is able to reverse the HG-induced upregulation of FOXO3a, p21, and p27 kip1 . Furthermore, miR-155-transduced BM CD34 pos cells formed fewer myeloid and erythroid colonies compared with scramble-transfected controls. The latter result replicates data from a previous study showing the ability of miR-155 in blocking differentiation in models of human hematopoiesis. 22 It remains unknown whether the described miR-dependent mechanism is implicated in other deficiencies of diabetic CD34 pos cells, including unresponsiveness to granulocyte colony-stimulating factor. Intriguingly, a recent study in healthy primates showed that granulocyte colonystimulating factor-mobilized CD34 pos cells express higher miR-155 levels compared with nonstimulated or Plerixaformobilized cells. 57 Altogether, these findings suggest that deregulation of the miR-155/FOXO3a/p27 signaling pathway might contribute to BM CD34 pos cell depletion in diabetes mellitus. More investigation is warranted to establish whether other HSC-associated miRs participate in determining an imbalance between endothelial progenitors and mature hematopoietic cells.
Clinical Implications
In conclusion, this study draws attention to the BM as a primary target of diabetes mellitus-induced damage. Our data suggest that the severity of systemic vascular disease has an impact on BM remodeling. Conversely, more severe BM pathologies can cause (or contribute to) macroangiopathy, through shortage of vascular regenerative cells. Moreover, it should be acknowledged that this study was conducted on aged subjects and that inference to a younger population is uncertain. Further research is warranted to find specific treatments able to preserve BM integrity in patients with diabetes mellitus.
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What Is Known?
• Diabetes mellitus is associated with reduced levels of circulating progenitor cells.
• Studies in diabetic animal models indicate the presence of microangiopathy in bone marrow endangering resident stem cell integrity.
• A restricted spectrum of microRNAs (miRs) that regulate self-renewal is expressed in hematopoietic stem cells.
What New Information Does This Article Contribute?
• In patients with diabetes mellitus, there is microangiopathy in the bone marrow, which is associated with incremental vascular damage in the presence of critical limb ischemia.
• The bone marrow of diabetic patients is depleted of hematopoietic and proangiogenic progenitor cells but not differentiated hematopoietic cells.
• Hyperglycemia inhibits miR-155, thereby releasing the activity of proapoptotic pathway involving FOXO3a/p21.
Although remodeling of blood vessels in peripheral organs has been extensively studied, little is known about the impact of common diseases on the marrow vascular niche, which is crucial for stem cell homeostasis and mobilization. Therefore, we investigated the effect of diabetes mellitus on bone marrow stem cells and their nurturing vasculature in humans. Results show a profound remodeling of the vascular niche, which is mainly replaced by fat, especially in patients with critical ischemia. Stem cell depletion did not preclude a regular abundance of mature hematopoietic cells, suggesting a defect in stem cell self-renewal. Investigation of underpinning mechanisms revealed that hyperglycemia inhibits a master regulator of hematopoietic cell fate, miR-155, thereby resulting in an unbalance between proliferation and differentiation. This was corrected by forced expression of miR-155. Our findings advance current understanding of pathological mechanisms leading to collapse of the vascular niche and reduced availability of proangiogenic cells. These data provide a key for interpretation of diabetes mellitus-associated defect in stem cell mobilization. In addition, our study reveals a negative circuitry, normally contrasted by a hematopoietic miR-responsible for pauperization of the marrow regenerative potential.
Supplemental Material Detailed Methods Study protocol and statistics
Primary endpoints of the study were BM capillary density and abundance of BM CD34 pos cells. Secondary endpoints comprise sinusoid and arteriole density and antigenic and transcriptional characteristics of CD34 pos cells. In pilot studies, we determined that a sample size of 7 in each of the 3 groups would have an 80% power to detect a difference between means of 13.6 capillaries per mm 2 with an expected average standard deviation of 8.3 and a significance level (alpha) of 0.05 (two-tailed). The same group size would have a 90% power to detect a difference between means of 1.1 CD34 pos cells/100 BM mononuclear cells (BM-MNCs) with an expected average standard deviation of 0.58. Recruitment of patients was continued until reaching the requested sample size as by power calculation for primary endpoints. Since patients were screened consecutively, the actual sample size eventually exceeded the minimum requested in 2 of the 3 groups. Moreover, depending on the dimensions of bone leftovers, we attempted to perform all the analyses on the same sample. When this was not possible, priority was given to histological analyses until reaching the requested group size and then to flow cytometry. Online Table II summarizes the samples attribution to different assays. In order to verify the direct effect of hyperglycemia on molecular mechanisms, CD34
pos -PCs were immunosorted from the BM of 5 non-diabetic patients undergoing hip replacement surgery and used for expressional studies and colony forming unit (CFU) assays, following exposure to HG with or without miR-155 forced expression. Results are presented as means±SEM. Normal distribution of the variables of interest was verified with D'agostino and Pearson test. data failed to pass normality or equal variance tests, non-parametric analysis was applied and results were expressed as median with 5-95 percentile distribution. For gene expression studies, logarithm transformation of the data was used followed by parametric tests. Multiple groups were compared by parametric analysis of variance (ANOVA), followed by Bonferroni t test, or non-parametric analysis of variance on ranks, followed by Tukey pairwise comparison or Dunnett's test for multiple comparisons against a single control group. Comparison of 2 groups was carried out by paired or unpaired Student t test or Mann-Whitney rank sum test. Comparison of categorical variables was made by chi-square test or Fisher's exact test. In addition, the Cohen's d index was calculated to determine if a statistically significant difference was of biological importance. The results of Cohen's d are considered to be small (< 0.5), medium (0.5 -0.8), or large (>0.8). In order to control the effects of background factors, means of dependent variables were compared and adjusted across the study groups by analysis of covariance (ANCOVA) (Online Tables III and IV) . Furthermore, multiple linear regression analyses were performed to verify if a given endpoint is predicted by combination of independent variables, including group, duration of diabetes, fasting glycemia, age, gender, coronary artery disease (CAD), stroke, hypertension, body mass index (BMI), smoking and treatment (Online Table V) . Since grouping factor, duration of diabetes and fasting glucose showed a high collinearity index (~2), each of the 3 independent variables was computed distinct from the other 2 in multiple linear regression analyses. The relationship between miR-155 and FOXO3a expression in CD34 pos cells was calculated using the Spearman correlation coefficient. A p value <0.05 was considered significant. Stated n values represent biological replicates.
Histomorphometry, immunohistochemistry, and immunofluorescence analyses
A femoral bone fragment of at least 0.5 cm 3 was fixed in 10% neutral buffered formalin, decalcified in 10% formic acid, and embedded in paraffin. Analyses were conducted on 3 micrometer-thick BM sections mounted on silane-coated slides (Dako, Denmark). Briefly, for histomorphometric studies, BM sections were stained with Hematoxylin-Eosin (HE) and images captured with a Nikon E800light microscope (Nikon, The Netherlands) were analyzed to assess the marrow composition using Image J, a Java-based processing program from the National Institutes of Health (NIH) (3 sections and 4-field/section for each patient). For immunohistochemistry, BM staining was conducted with primary antibodies followed by appropriate secondary antibody (Online Table VI) . A Peroxidase/DAB commercial kit
Immunofluorescence microscopy was performed by incubating BM sections with appropriately diluted primary antibodies overnight at 4°C, followed by secondary fluorescence-conjugated antibodies for 1 hour at room temperature. Image acquisition was carried out with a confocal laser microscope (Leica TCS-SP2, Leica Microsystems, Germany). In addition, percentage of apoptotic BM cells was measured as function of FITC-positive nuclei that bear DNA breaks labeled by TUNEL assay (Calbiochem, Germany). Fluorescence was visualized and captured using AXIO OBSERVER A1 microscope equipped with digital image processing software (AxioVision Imaging System), both from Zeiss (Germany).
Cell isolation and culture
MNCs were isolated from total BM single cell suspension by centrifugation on Histopaque-1077 density medium (Sigma, St. Louis, USA). CD34 pos cells were separated from BM-MNCs by magnetic bead-assisted cell sorting (MACS, MiltenyiBiotec, Germany). CD34 purity was ~80% as confirmed by flow cytometry. Cells were then used for molecular biology studies either immediately after sorting or following exposure to high glucose (HG). To the latter aim, CD34 pos cells were cultured for 24 hours in standard medium (EBM) (LONZA, Switzerland), 10% fetal bovine serum (FBS), human Stem Cell Factor (hSCF, 100ng/mL) (RD, USA), interleukin 3 (IL3, 20 ng/mL), and FMS Like Tyrosine Kinase 3 Ligand (Flt3-L, 100ng/mL) (both from Provitro Gmbh, Germany) containing 5 mM D-glucose (normal glucose, NG), or 25mM D-glucose (HG). Preservation of the antigenic profile after cell culture was confirmed by flow cytometry.
miR-155 Transfection
CD34
pos were transfected with 50 nmol/L pre-miR-155 or negative control (a non-targeting sequence, also identified as scramble, SCR, throughout the manuscript) (all from Applied Biosystems) using GeneSilencer (Dharmacon) following the manufacturer's instructions. Changes in relative miR-155 expression were measured by TaqMan PCR (vide infra).
Colony Forming Unit Assay CD34
pos cells were transduced with miR-155or scramble control (Applied Biosystem) as mentioned above and used in standard colony-forming unit (CFU) assays for myeloid and erythroid differentiation following the manufacturer's instructions (Stem Cells Technologies). Colonies were harvested at day 14 and isolated cells were placed on glass slides for staining with specific markers. In particular, myeloperoxidase (MPO), a marker of granulocytes, was used to stain cells in CFU-GEMM colonies, CD68, a marker of macrophages, to stain cells from CFU-GM colonies, and glyphorin, a marker of erythrocutes to characterize cells from CFU-E colonies.
Flow cytometry
The following cell populations were identified within BM-MNCs and PB-MNCs as previously described in detail: pos cells fixed in 70% ethanol solution for 18 hours at -20°C. Cells were then washed twice with cold PBS, incubated in a 0.1% TritonX-100, 0.1% sodium citrate, 50g/ml propidium iodide solution for 40min at 37°C in the dark, and analyzed by flow cytometry within 45 min. For each test, 1X10 5 to 5X10 6 total events were analyzed in a FACSCanto flow cytometer using the FACSDiva software (both from BD Biosciences, New Jersey, USA).
RT-PCR analysis on sorted CD34
pos BM-MNCs Online 
